Julia Natterer
Overview
Explore the profile of Julia Natterer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perez M, Longchamp D, Amiet V, Natterer J, Ferry T, Boegli Y, et al.
Int J Cardiol Congenit Heart Dis
. 2024 Dec;
8:100383.
PMID: 39712060
Children with cyanotic congenital heart diseases have a higher risk of bleeding or thrombosis. Rotational thromboelastometry, using tissue factor (EXTEM), a contact activator (INTEM), or cytochalasin (FIBTEM), assesses coagulation by...
2.
Toure I, Maitre G, Boillat L, Chanez V, Natterer J, Ferry T, et al.
Clin Nutr ESPEN
. 2023 May;
55:384-391.
PMID: 37202072
Background And Aims: Daily caloric and protein intake is crucial for the management of critically ill children. The benefit of feeding protocols in improving daily nutritional intake in children remains...
3.
Rizzati F, Marie G, Chanez V, Ferry T, Natterer J, Longchamp D, et al.
Front Pediatr
. 2023 Mar;
11:1042509.
PMID: 36937972
Reversible cerebral vasoconstriction syndrome (RCVS) is a vascular disease characterized by diffuse transient vasoconstriction and vasodilatation of the cerebral arteries. It is commonly associated with recurrent severe acute headaches with...
4.
Natterer J, Schneider J, Sekarski N, Rathke V, Adams M, Latal B, et al.
Swiss Med Wkly
. 2022 Sep;
152:w30217.
PMID: 36074038
Introduction: Congenital heart disease (CHD) is the most frequent birth defect. As survival has significantly improved, attention has turned to neurodevelopmental outcomes of children undergoing heart surgery in early infancy....
5.
Natterer J, Rizzati F, Perez M, Longchamp D, Amiet V, DeHalleux Q, et al.
J Pediatr Intensive Care
. 2022 Feb;
11(1):67-71.
PMID: 35178280
In this article, we reported the case of a child patient who was admitted to our PICU for severe acute respiratory distress syndrome (ARDS) while being treated with trimethoprim-sulfamethoxazole (TMP-SMX)...
6.
Didisheim C, Ballhausen D, Choucair M, Longchamp D, Natterer J, Ferry T, et al.
J Pediatr Intensive Care
. 2021 Nov;
10(4):307-310.
PMID: 34745706
In this article, we presented a teenager, in maintenance chemotherapy for leukemia, who was admitted for digestive symptoms related to a parasitic infection and required nutritional support with parenteral nutrition....
7.
Perez Marin M, ProdHom S, de Villiers S, Ferry T, Amiet V, Natterer J, et al.
Front Pediatr
. 2021 Apr;
9:658347.
PMID: 33898365
Colchicine poisoning is associated with a poor prognosis, especially when leading to shock and multi-organ failure, and management is limited to supportive care, including multiple-dose activated charcoal. At therapeutic concentrations,...
8.
Ferry T, Amiet V, Natterer J, Perez M, Pfister R, Colombier S, et al.
Scand J Trauma Resusc Emerg Med
. 2021 Mar;
29(1):48.
PMID: 33722251
Background: Chloroquine use has increased worldwide recently in the setting of experimental treatment for the novel coronavirus disease (Covid-19). Nevertheless, in case of chloroquine intoxication, it can be life threatening,...
9.
Pfister R, Kirsch M, Natterer J, Di Bernardo S, Pretre R
Pediatr Cardiol
. 2019 Nov;
41(2):423-424.
PMID: 31679056
Left ventricular assist device is a well-established therapy in heart failure adults, but less in children. A 13-year-old-boy with severe left ventricular dysfunction did not improve under medical treatment. A...
10.
Perez Marin M, Decosterd L, Andre P, Buclin T, Mercier T, Murray K, et al.
J Pediatric Infect Dis Soc
. 2019 Jun;
9(1):96-99.
PMID: 31183500
Little information on the efficacy and pharmacokinetics of letermovir among immunocompromised children is currently available. We describe here the use of letermovir in a 2-year-old immunocompromised child with ganciclovir-resistant cytomegalovirus...